Somatostatin (SST)b exerts diverse biological actions through a family of five cell surface SST receptors (SSTR) subtypes. These can be categorized into two subgroups, one consisting of SSTRs 2,3 and 5 and the other made up of SSTRs 1 and 4 on the basis of their ability or inability to bind octa-and hexa-peptide SST analogs [1, 2] . SST influences multiple second messenger systems including adenylyl cyclase-cAMP, Ca2+, K+, protein tyrosine phosphatase (PTP), protein serine phosphatase, mitogen activated protein kinase and Na+/H+ antiporter, and exerts an inhibitory effect on hormone secretion, cell growth and proliferation (reviewed in [1] [2] [3] [17, 18] . Here I summarize current evidence demonstrating that SST elicits cytotoxic action uniquely via hSSTR3 in a p53 dependent manner whereas its cytostatic action is exerted through other subtypes involving induction of pRB in a p53-independent manner. We first assessed the subtype selectivity for regulating cell cycle in CHO-Ki cells stably expressing individual hSSTRs. Cells were treated with 100 nM OCT (hSSTRs 2, 3, 5) 
Somatostatin (SST)b exerts diverse biological actions through a family of five cell surface SST receptors (SSTR) subtypes. These can be categorized into two subgroups, one consisting of SSTRs 2,3 and 5 and the other made up of SSTRs 1 and 4 on the basis of their ability or inability to bind octa-and hexa-peptide SST analogs [1, 2] . SST influences multiple second messenger systems including adenylyl cyclase-cAMP, Ca2+, K+, protein tyrosine phosphatase (PTP), protein serine phosphatase, mitogen activated protein kinase and Na+/H+ antiporter, and exerts an inhibitory effect on hormone secretion, cell growth and proliferation (reviewed in [1] [2] [3] ). SST-induced inhibition of cell proliferation can elicit either cytostatic (growth arrest) as well as cytotoxic (apoptosis) in tumor cells which express multiple SSTR subtypes [4] [5] [6] [7] [8] [9] . We have shown that SSTR mediated cytotoxic signaling in MCF-7 breast cancer cells involves rapid recruitment of the src homology 2 domain containing tyrosine phosphatase SHP-1, is associated with the induction of the wild type (wt) tumor suppressor protein p53, the proapoptotic protein Bax and a cationinsensitive acidic endonuclease [9, 10] . The mechanism underlying its cytostatic signaling reported to occur in other tumor cells such as GH3 cells has not been elucidated.
Molecular mediators that regulate cytotoxic and cytostatic events include the tumor suppressor protein p53, the cyclin dependent kinase inhibitor p2lWAFl/CIPl, the retinoblastoma protein pRB and the protooncogene product c-Myc. p53 can induce GI cell cycle arrest via p2lWAFl/CIPI in the presence of growth factors or trigger apoptosis by inducing Bax in the absence of mitogenic signals [11] [12] [13] . Both these actions of p53 are dependent on its ability to acquire wt conformation in a manner requiring dephosphorylation of phosphoserine residues [14] . c-Myc, like p53, can also induce either G1 arrest or apoptosis and moreover, can abrogate p2lwAFl/cIPl induced G1 arrest [15] . pRB in its hypophosphorylated form induces G, cell cycle arrest independent of p53 [16] . In order to determine if SST influences these mediators in a SSTR subtype selective manner to differentially regulate cell cycle progression and apoptosis we set out to elucidate human (h) SSTR subtype selectivity for cytotoxic and cytostatic signaling and demonstrated that SST-induced apoptosis is signaled uniquely via hSSTR3 whereas the other hSSTR subtypes signal G, cell cycle arrest without inducing apoptosis [17, 18] . Here I summarize current evidence demonstrating that SST elicits cytotoxic action uniquely via hSSTR3 in a p53 dependent manner whereas its cytostatic action is exerted through other subtypes involving induction of pRB in a p53-independent manner. We first assessed the subtype selectivity for regulating cell cycle in CHO-Ki cells stably expressing individual hSSTRs. Cells were treated with 100 nM OCT (hSSTRs 2, 3, 5) a To whom all correspondence should be addressed: Coimbatore (Figure 1 ). In cells expressing hSSTR3, OCT induced a decrease in GI and an increase in S phase indicating that it triggered cell cycle progression via this subtype. By contrast, cells expressing other SSTR subtypes responded with decreased cell proliferation, with the percentage of cells increasing in G1 relative to S demonstrating that hSSTRs 1,2,4 and 5 signal G1 cell cycle arrest. Such cytostatic signaling was associated with the induction of pRB (hSSTR5>hSSTR2>hSSTTR4>hSSTR1) (Figure 2 ). The cytotoxic signaling via hSSTR3 as well as the cytostatic signaling through the other hSSTRs was pertussis toxin sensitive G protein dependent and was mediated by orthovanadate sensitive PTP [17] In CHO-KI cells expressing hSSTR3 the antiproliferative action of OCT led to the induction of wt p53 and apoptosis. The activity of tumor suppressor protein p53 is regulated by Ser phosphorylation. p53 is believed to be in an inactive conformation in its phosphorylated form and assumes its active conformation upon dephosphorylation of Ser residues [14] . These forms can be distinguished by using epitope-specific anti-p53 antibodies pAb 240 and pAb 1801: only the inactive form of (or mutant) p53 is recognized by pAb 240, whereas both the inactive and active forms bind to pAb 1801. The results summarized in Figure 3 show that OCT induces a 10-fold increase in wt p53 in its active conformation detected with hSSTRs. By contrast, no change was observed in p53 recognized by the mutant-specific anti-p53 antibody pAb 240 as described in detail previously by us [17] . Analysis of cells dual labeled with pAb 1801 and PI revealed that hSSTR3 signaled increase in wt p53 occurs in all phases of the cell cycle during treatment with OCT for 96 hr (Figure 4 ). Bivariate analysis of dual labeled cells depicted as 3-D Isocontour plots illustrate the decrease in G1 with concomitant accumulation of cells with hypodiploid DNA content in the region marked AO. The presence of subdiploid DNA peak is a hallmark for apoptosis. That OCT induces apoptosis in hSSTR3 expressing cells in a timedependent manner was confirmed by the detection of oligonucleosome sized DNA fragments by inversion field gel electrophoresis [17] . wt p53 is known to trigger either G1 arrest or apoptosis. hSSTR3 initiated increase in p53 did not cause G1 cell cycle arrest. In support of this is our finding that OCT did not influence either p21wAFl/cIPl (required for p53-induced GI arrest) or c-Myc (needed for abrogating p21wAFl/cIP1 mediated GI arrest) in these cells [17] . We have shown that hSSTR3 mediated induction of wt p53 occurs within minutes, increases in a time-dependent manner and precedes the induction of Bax and the onset of apoptosis [17] . Furthermore, p53 exhibits perinuclear localization in untreated cells but display preferential intranuclear accumulation concomitant with nuclear shrinkage, a characteristic feature of cells undergoing apoptosis [17] .
Based on these findings, I propose the following mechanistic model of hSSTR3 initiated cytotoxic signaling ( Figure 5 ). The first event in this signal cascade is the regulation of a SST-sensitive PTP in a G protein dependent manner. The principal mediator of cytotoxic signaling initiated through hSSTR3 is wt p53 in its active conformation. A rapid, time-dependent increase in wt p53 and its nuclear translocation occurs in OCT-treated cells and precedes the onset of apoptosis. This, in turn, leads to the activation of Bax and acidic endonuclease, thereby causing oligonucleosomal DNA fragmentation and apoptosis. The nuclear accumulation of wt p53 parallels nuclear shrinking, a characteristic feature of apoptosis. The increased pAb 1801 immunoreactive wt p53 as well as its activation are dependent on dephosphorylation of Ser residues suggesting that by hSSTR3 linked PTP may activate SerlThr phosphatase(s) [14, 17] . SST-sensitive PTP has been implicated in attenuating growth factor receptor kinase induced mitogenic signaling [19, 20] . Inhibition of mitogenic signaling via hSSTR3 may, therefore, be conducive for induction of wt p53 dependent apoptosis. PTP dependent antiproliferative signaling through other SSTR subtypes may lead to Gi arrest since these do not induce either wt p53 or apoptosis. This raises the question of whether hSSTR3 and other SSTR subtypes signal through different PTPs. We have recently reported that membrane associated PTP is not directly activated in tumor cells, contradicting previous claims [10, 19, 20] . We demonstrated that a net increase in membrane-associated PTP occurs in MCF-7 breast cancer cells preincubated with OCT and, additionally, have identified SHP-1 (PTPIC/SHPTP1I/HCP/ SHP) as the intracellular PTP recruited by OCT in a time-and concentration-dependent manner [10] . Studies are in progress to delineate the role of SHP-1 in subtype-selective hSSTR-mediated cytotoxic and cytostatic signaling.
We have shown that OCT induced cytotoxic signaling in MCF-7 cells occurs in a p53 dependent manner, requiring the downstream induction of Bax and cation-insensitive acidic endonuclease [9] . Surprisingly, the rate of cytotoxic signaling was faster in MCF-7 cells compared to CHO-KI cells expressing hSSTR3 [9] . [7] [8] [9] 22] . This may be due to functional differences between human and rat SSTR3 or, alternatively, due to mutation in the p53 molecule may render it incapable of assuming the active conformation in GH3 cells. Overexpression of Bax has been shown to sensitize MCF-7 cells to radiation [23] . Agonist-dependent SSTR internalization has been observed in tumor cells and is reported to occur maximally via hSSTR3 [24, 25] . The selectivity of hSSTR3 for inducing Bax in wt p53-dependent manner, combined with its ability to sequester the ligand within the cell, provides a rational basis for exploiting the therapeutic potential of a-and ,B-emitting OCT tagged radionuclides such as "'In, 99Tc, 67/68Ga and 161Tb in the treatment of tumors expressing hSSTR3 and wt p53. Such compounds are already in use for scintigraphic visualization of SSTR-positive tumors [26] [27] [28] [29] .
Tamoxifen potentiates the cytotoxic activity of OCT in two estrogen-responsive cell lines MCF-7, T47-D and ZR-75-1 (Sharma and Srikant, unpublished observations). A positive influence of OCT enhancing the antineoplastic effect of tamoxifen and ovariectomy has also been reported in vivo on 7,12-dimethylbenzanthracene-induced mammary carcinoma [30] . Its cytotoxic and/or cytostatic activity in vivo is difficult to assess since SST exerts growth inhibitory action indirectly also by decreasing growth factor (e.g., IGF-1) bioavailability, [31, 32] .
In summary, cytotoxic signaling of SST resulting in apoptosis is selectively transduced through hSSTR3. Such cytotoxic signaling requires dephosphorylation dependent conformational change and activation of wt p53, and its rapid nuclear translocation followed by induction of Bax and acidic endonuclease. These events occur in cells actively traversing the cell cycle. Since hSSTR3 bound agonist is maximally intemalized, I predict that a-and I-emitting OCT-tagged radionuclides will be most useful in treating tumors expressing hSSTR3 and wt p53, not only because of receptor mediated cytotoxic signaling, but also due to greater sensitization by hormonally induced Bax to radiation damage by internalized radioactivity as a consequence of receptor-mediated endocytosis. 
